| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.678 | 0.026 | 0.678 | Caspase 9 stimulant | 0.638 0.031 CID_154699725 | ||
| 0.659 | 0.012 | 0.659 | Aldehyde oxidase inhibitor | |||
| 0.589 | 0.005 | 0.589 | Peroxidase inhibitor | |||
| 0.589 | 0.009 | 0.589 | GABA C receptor rho-3 antagonist | |||
| 0.586 | 0.018 | 0.586 | Streptokinase A inhibitor | |||
| 0.578 | 0.015 | 0.578 | 12-Lipoxygenase inhibitor | |||
| 0.531 | 0.007 | 0.531 | Pyruvate kinase inhibitor | 0.198 0.082 CID_154699725 | ||
| 0.526 | 0.005 | 0.788 | Amylase inhibitor | 0.788 0.002 CID_154699725 | CID_154699725 | |
| 0.52 | 0.007 | 0.52 | ErbB-1 antagonist | |||
| 0.486 | 0.004 | 0.486 | Estrogen receptor beta antagonist | |||
| 0.473 | 0.004 | 0.473 | Alcohol oxidase inhibitor | 0.054 0.041 CID_154699725 | ||
| 0.488 | 0.029 | 0.488 | 5 Hydroxytryptamine release stimulant | 0.279 0.077 CID_154699725 | ||
| 0.524 | 0.067 | 0.698 | Apoptosis agonist | 0.698 0.031 CID_154699725 | CID_154699725 | |
| 0.479 | 0.023 | 0.479 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.467 | 0.013 | 0.467 | RNA-directed DNA polymerase inhibitor | 0.41 0.017 CID_154699725 | ||
| 0.456 | 0.004 | 0.456 | Estrogen antagonist | 0.1 0.099 CID_154699725 | ||
| 0.461 | 0.02 | 0.673 | Free radical scavenger | 0.673 0.005 CID_154699725 | CID_154699725 | |
| 0.483 | 0.044 | 0.483 | 15-Lipoxygenase inhibitor | |||
| 0.438 | 0.003 | 0.438 | Histidine decarboxylase inhibitor | 0.078 0.044 CID_154699725 | ||
| 0.438 | 0.005 | 0.438 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.456 | 0.028 | 0.456 | Caspase 3 stimulant | 0.423 0.037 CID_154699725 | ||
| 0.473 | 0.047 | 0.473 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.418 | 0.008 | 0.65 | Alpha-N-acetylglucosaminidase inhibitor | 0.65 0.003 CID_154699725 | CID_154699725 | |
| 0.421 | 0.012 | 0.421 | Dual specificity phosphatase inhibitor | |||
| 0.453 | 0.05 | 0.525 | 5 Hydroxytryptamine release inhibitor | 0.525 0.025 CID_154699725 | CID_154699725 | |
| 0.413 | 0.012 | 0.413 | Dual specificity phosphatase 3 inhibitor | |||
| 0.428 | 0.03 | 0.719 | Antioxidant | 0.719 0.005 CID_154699725 | CID_154699725 | |
| 0.397 | 0.008 | 0.397 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.33 0.016 CID_154699725 | ||
| 0.415 | 0.035 | 0.415 | Aryl hydrocarbon receptor agonist | |||
| 0.466 | 0.09 | 0.719 | Alpha-glucosidase inhibitor | 0.719 0.03 CID_154699725 | CID_154699725 | |
| 0.379 | 0.005 | 0.379 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.378 | 0.007 | 0.502 | UDP-glucose 4-epimerase inhibitor | 0.502 0.003 CID_154699725 | CID_154699725 | |
| 0.387 | 0.021 | 0.387 | Sodium/bile acid cotransporter inhibitor | 0.286 0.092 CID_154699725 | ||
| 0.391 | 0.026 | 0.391 | Amyloid beta aggregation inhibitor | 0.18 0.089 CID_154699725 | ||
| 0.371 | 0.007 | 0.371 | Aldehyde dehydrogenase inhibitor | 0.324 0.009 CID_154699725 | ||
| 0.369 | 0.006 | 0.369 | GABA C receptor agonist | 0.094 0.073 CID_154699725 | ||
| 0.386 | 0.028 | 0.386 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.375 | 0.019 | 0.375 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.386 | 0.03 | 0.386 | Calcium channel activator | |||
| 0.423 | 0.067 | 0.693 | Antibacterial | 0.693 0.009 CID_154699725 | CID_154699725 | |
| 0.376 | 0.031 | 0.376 | Superoxide dismutase inhibitor | |||
| 0.359 | 0.022 | 0.359 | Anesthetic general | 0.337 0.026 CID_154699725 | ||
| 0.342 | 0.005 | 0.342 | Nitric-oxide synthase stimulant | 0.34 0.005 CID_154699725 | ||
| 0.365 | 0.029 | 0.365 | Transcription factor STAT inhibitor | |||
| 0.335 | 0.005 | 0.335 | Estrogen agonist | 0.086 0.021 CID_154699725 | ||
| 0.406 | 0.077 | 0.406 | Calcium channel L-type activator | |||
| 0.36 | 0.035 | 0.36 | Dyrk kinase inhibitor | |||
| 0.379 | 0.054 | 0.654 | Cholesterol antagonist | 0.654 0.012 CID_154699725 | CID_154699725 | |
| 0.353 | 0.032 | 0.353 | Transcription factor STAT3 inhibitor | 0.2 0.134 CID_154699725 | ||
| 0.397 | 0.077 | 0.499 | Histamine release inhibitor | 0.499 0.029 CID_154699725 | CID_154699725 | |
| 0.32 | 0.003 | 0.32 | Glutamate decarboxylase inhibitor | 0.082 0.043 CID_154699725 | ||
| 0.332 | 0.017 | 0.453 | DNA methyltransferase I inhibitor | 0.453 0.005 CID_154699725 | CID_154699725 | |
| 0.319 | 0.005 | 0.333 | Mannose-6-phosphate isomerase inhibitor | 0.333 0.004 CID_154699725 | CID_154699725 | |
| 0.328 | 0.015 | 0.328 | Protein-tyrosine phosphatase inhibitor | 0.239 0.034 CID_154699725 | ||
| 0.32 | 0.009 | 0.474 | Hexokinase inhibitor | 0.474 0.003 CID_154699725 | CID_154699725 | |
| 0.32 | 0.012 | 0.32 | Heat shock protein 90 alpha antagonist | |||
| 0.313 | 0.005 | 0.313 | Carbonic anhydrase VI inhibitor | 0.137 0.024 CID_154699725 | ||
| 0.312 | 0.005 | 0.312 | Porphobilinogen synthase inhibitor | |||
| 0.33 | 0.026 | 0.33 | MAP kinase kinase 2 inhibitor | |||
| 0.322 | 0.018 | 0.322 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.322 | 0.022 | 0.464 | DNA methylase inhibitor | 0.464 0.007 CID_154699725 | CID_154699725 | |
| 0.308 | 0.01 | 0.308 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.298 | 0.004 | 0.298 | Creatine kinase inhibitor | |||
| 0.301 | 0.009 | 0.301 | Cystathionine beta-synthase inhibitor | 0.255 0.014 CID_154699725 | ||
| 0.343 | 0.053 | 0.343 | Lipoxygenase inhibitor | |||
| 0.294 | 0.005 | 0.294 | Alcohol dehydrogenase inhibitor | 0.225 0.01 CID_154699725 | ||
| 0.304 | 0.017 | 0.598 | Monophenol monooxygenase inhibitor | 0.598 0.005 CID_154699725 | CID_154699725 | |
| 0.301 | 0.015 | 0.301 | MAO A inhibitor | |||
| 0.357 | 0.074 | 0.357 | Thioredoxin glutathione reductase inhibitor | |||
| 0.332 | 0.051 | 0.368 | Hypoxia-inducible factor 1 alpha inhibitor | 0.368 0.039 CID_154699725 | CID_154699725 | |
| 0.298 | 0.02 | 0.298 | MAO inhibitor | |||
| 0.278 | 0.004 | 0.278 | Estrogen receptor beta agonist | 0.042 0.021 CID_154699725 | ||
| 0.285 | 0.012 | 0.285 | Heat shock protein 90 antagonist | |||
| 0.284 | 0.013 | 0.284 | Succinate dehydrogenase inhibitor | 0.159 0.097 CID_154699725 | ||
| 0.29 | 0.021 | 0.466 | Interferon gamma antagonist | 0.466 0.008 CID_154699725 | CID_154699725 | |
| 0.29 | 0.025 | 0.29 | Mcl-1 antagonist | |||
| 0.284 | 0.021 | 0.284 | Amyloid beta precursor protein antagonist | |||
| 0.267 | 0.005 | 0.267 | Uric acid excretion stimulant | 0.249 0.007 CID_154699725 | ||
| 0.263 | 0.004 | 0.263 | GABA aminotransferase inhibitor | 0.214 0.004 CID_154699725 | ||
| 0.313 | 0.055 | 0.313 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.265 | 0.008 | 0.678 | Beta glucuronidase inhibitor | 0.678 0.003 CID_154699725 | CID_154699725 | |
| 0.338 | 0.081 | 0.67 | Transcription factor NF kappa B inhibitor | 0.67 0.024 CID_154699725 | CID_154699725 | |
| 0.264 | 0.008 | 0.264 | Carbonic anhydrase III inhibitor | 0.147 0.03 CID_154699725 | ||
| 0.268 | 0.014 | 0.268 | Protein-tyrosine phosphatase 1B inhibitor | 0.227 0.022 CID_154699725 | ||
| 0.257 | 0.004 | 0.257 | Estrogen receptor alpha agonist | |||
| 0.263 | 0.011 | 0.263 | Ferrochelatase inhibitor | |||
| 0.254 | 0.004 | 0.254 | DOPA decarboxylase inhibitor | 0.098 0.08 CID_154699725 | ||
| 0.263 | 0.015 | 0.263 | Chelator | |||
| 0.298 | 0.05 | 0.854 | Angiogenesis stimulant | 0.854 0.003 CID_154699725 | CID_154699725 | |
| 0.251 | 0.005 | 0.251 | Interleukin 8 antagonist | 0.119 0.063 CID_154699725 | ||
| 0.301 | 0.058 | 0.301 | Insulysin inhibitor | |||
| 0.266 | 0.024 | 0.385 | Lipid peroxidase inhibitor | 0.385 0.01 CID_154699725 | CID_154699725 | |
| 0.261 | 0.019 | 0.261 | NADPH oxidase inhibitor | 0.191 0.037 CID_154699725 | ||
| 0.254 | 0.012 | 0.621 | Expectorant | 0.621 0.003 CID_154699725 | CID_154699725 | |
| 0.241 | 0.005 | 0.241 | Aldose reductase inhibitor | 0.186 0.008 CID_154699725 | ||
| 0.236 | 0.003 | 0.236 | D-Ala-D-Ala ligase inhibitor | |||
| 0.283 | 0.05 | 0.445 | DNA synthesis inhibitor | 0.445 0.017 CID_154699725 | CID_154699725 | |
| 0.241 | 0.009 | 0.241 | Potassium channel (Ca-activated) activator | |||
| 0.325 | 0.099 | 0.325 | Calpain 2 inhibitor | |||
| 0.243 | 0.018 | 0.243 | MAO B inhibitor | |||
| 0.233 | 0.008 | 0.233 | Urease inhibitor | |||
| 0.241 | 0.016 | 0.393 | ATPase inhibitor | 0.393 0.004 CID_154699725 | CID_154699725 | |
| 0.318 | 0.094 | 0.318 | Prostaglandin dehydrogenase inhibitor | |||
| 0.257 | 0.034 | 0.257 | I kappa B kinase epsilon inhibitor | |||
| 0.249 | 0.026 | 0.249 | Histone acetyltransferase inhibitor | |||
| 0.243 | 0.021 | 0.25 | Alkaline phosphatase inhibitor | 0.25 0.02 CID_154699725 | CID_154699725 | |
| 0.23 | 0.009 | 0.23 | Aminoacyl-tRNA synthetase inhibitor | 0.117 0.032 CID_154699725 | ||
| 0.231 | 0.011 | 0.231 | Arachidonic acid antagonist | 0.184 0.049 CID_154699725 | ||
| 0.244 | 0.026 | 0.244 | Phospholipase C inhibitor | 0.199 0.045 CID_154699725 | ||
| 0.232 | 0.014 | 0.232 | Carbonic anhydrase XV inhibitor | |||
| 0.253 | 0.037 | 0.259 | Neurotrophic factor enhancer | 0.259 0.034 CID_154699725 | CID_154699725 | |
| 0.222 | 0.008 | 0.222 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.229 | 0.017 | 0.229 | GABA C receptor rho-2 antagonist | |||
| 0.267 | 0.056 | 0.267 | Interleukin antagonist | |||
| 0.232 | 0.021 | 0.232 | Adenylate cyclase inhibitor | 0.149 0.045 CID_154699725 | ||
| 0.298 | 0.087 | 0.565 | Apoptosis antagonist | 0.565 0.013 CID_154699725 | CID_154699725 | |
| 0.219 | 0.01 | 0.219 | 5 Hydroxytryptamine 3A agonist | |||
| 0.213 | 0.005 | 0.223 | Heat shock protein 70 antagonist | 0.223 0.005 CID_154699725 | CID_154699725 | |
| 0.221 | 0.013 | 0.315 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.315 0.005 CID_154699725 | CID_154699725 | |
| 0.216 | 0.01 | 0.229 | Mucolytic | 0.229 0.009 CID_154699725 | CID_154699725 | |
| 0.211 | 0.008 | 0.211 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.218 | 0.018 | 0.218 | Cathepsin H inhibitor | 0.107 0.094 CID_154699725 | ||
| 0.295 | 0.096 | 0.295 | Thyroid hormone antagonist | |||
| 0.207 | 0.009 | 0.207 | TRPA1 agonist | 0.137 0.041 CID_154699725 | ||
| 0.204 | 0.006 | 0.204 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.198 | 0.004 | 0.198 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.195 0.004 CID_154699725 | ||
| 0.204 | 0.011 | 0.34 | Phosphofructokinase-1 inhibitor | 0.34 0.004 CID_154699725 | CID_154699725 | |
| 0.337 | 0.144 | 0.337 | DNA directed DNA polymerase inhibitor | |||
| 0.211 | 0.017 | 0.312 | Xanthine oxidase inhibitor | 0.312 0.007 CID_154699725 | CID_154699725 | |
| 0.24 | 0.047 | 0.502 | Non-steroidal antiinflammatory agent | 0.502 0.007 CID_154699725 | CID_154699725 | |
| 0.199 | 0.008 | 0.199 | CYP2A6 inhibitor | |||
| 0.213 | 0.024 | 0.213 | MAP kinase kinase inhibitor | |||
| 0.197 | 0.008 | 0.197 | Macrophage migration inhibitory factor inhibitor | |||
| 0.199 | 0.011 | 0.408 | Triose-phosphate isomerase inhibitor | 0.408 0.003 CID_154699725 | CID_154699725 | |
| 0.202 | 0.014 | 0.202 | NMDA receptor antagonist | |||
| 0.212 | 0.024 | 0.212 | Catenin beta inhibitor | |||
| 0.195 | 0.011 | 0.396 | NADH dehydrogenase inhibitor | 0.396 0.005 CID_154699725 | CID_154699725 | |
| 0.332 | 0.148 | 0.332 | DNA polymerase beta inhibitor | |||
| 0.196 | 0.014 | 0.196 | GABA C receptor antagonist | |||
| 0.221 | 0.039 | 0.221 | Cytidine deaminase inhibitor | |||
| 0.203 | 0.022 | 0.203 | Toll-Like receptor 2 antagonist | |||
| 0.243 | 0.063 | 0.243 | Neuropeptide Y2 antagonist | |||
| 0.187 | 0.009 | 0.187 | Estrogen receptor alpha antagonist | |||
| 0.203 | 0.025 | 0.203 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.191 | 0.015 | 0.282 | Photosensitizer | 0.282 0.005 CID_154699725 | CID_154699725 | |
| 0.184 | 0.008 | 0.184 | Potassium channel large-conductance Ca-activated activator | |||
| 0.192 | 0.016 | 0.192 | Adenylate kinase inhibitor | 0.153 0.025 CID_154699725 | ||
| 0.279 | 0.106 | 0.456 | Vasodilator, coronary | 0.456 0.022 CID_154699725 | CID_154699725 | |
| 0.191 | 0.018 | 0.191 | Adenylate cyclase stimulant | 0.136 0.089 CID_154699725 | ||
| 0.192 | 0.02 | 0.192 | Protein kinase (CK2) inhibitor | |||
| 0.251 | 0.079 | 0.282 | DNA damaging | 0.282 0.065 CID_154699725 | CID_154699725 | |
| 0.317 | 0.146 | 0.317 | Transcription factor inhibitor | |||
| 0.188 | 0.017 | 0.188 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.196 | 0.025 | 0.196 | Protein kinase (CK2) alpha inhibitor | |||
| 0.195 | 0.025 | 0.195 | 5-Lipoxygenase inhibitor | |||
| 0.177 | 0.009 | 0.177 | Ca2+-transporting ATPase inhibitor | 0.171 0.012 CID_154699725 | ||
| 0.19 | 0.022 | 0.19 | Histone deacetylase class III inhibitor | |||
| 0.241 | 0.074 | 0.241 | Calpain inhibitor | |||
| 0.19 | 0.023 | 0.19 | Aurora-C kinase inhibitor | |||
| 0.2 | 0.033 | 0.2 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.19 | 0.025 | 0.19 | Farnesoid X receptor antagonist | |||
| 0.169 | 0.004 | 0.169 | Prostaglandin F2 alpha antagonist | 0.092 0.015 CID_154699725 | ||
| 0.175 | 0.011 | 0.175 | Transcription factor STAT6 inhibitor | |||
| 0.198 | 0.035 | 0.198 | Cyclooxygenase 1 inhibitor | 0.108 0.091 CID_154699725 | ||
| 0.172 | 0.01 | 0.172 | MAP kinase kinase 1 inhibitor | |||
| 0.167 | 0.004 | 0.167 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.175 | 0.014 | 0.175 | Prolactin inhibitor | |||
| 0.197 | 0.037 | 0.197 | CDC-like kinase 1 inhibitor | |||
| 0.209 | 0.049 | 0.209 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.164 | 0.005 | 0.164 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.169 | 0.011 | 0.169 | Carbonic anhydrase V inhibitor | |||
| 0.196 | 0.037 | 0.196 | Neurotensin receptor agonist | |||
| 0.198 | 0.042 | 0.359 | Melanin inhibitor | 0.359 0.015 CID_154699725 | CID_154699725 | |
| 0.186 | 0.031 | 0.186 | CF transmembrane conductance regulator agonist | 0.134 0.109 CID_154699725 | ||
| 0.16 | 0.005 | 0.16 | NMDA receptor subunit 3B antagonist | |||
| 0.157 | 0.003 | 0.157 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.167 | 0.013 | 0.167 | NMDA 2 receptor antagonist | |||
| 0.155 | 0.002 | 0.155 | Estrogen-related receptor beta antagonist | |||
| 0.168 | 0.015 | 0.168 | GABA C receptor rho-1 antagonist | |||
| 0.172 | 0.019 | 0.172 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.159 | 0.006 | 0.159 | NMDA 2A receptor antagonist | |||
| 0.18 | 0.027 | 0.488 | Cyclooxygenase 3 inhibitor | 0.488 0.003 CID_154699725 | CID_154699725 | |
| 0.171 | 0.019 | 0.171 | Epidermal growth factor antagonist | |||
| 0.181 | 0.032 | 0.181 | Cholesterol synthesis inhibitor | 0.132 0.056 CID_154699725 | ||
| 0.175 | 0.028 | 0.175 | MAP kinase kinase 4 inhibitor | |||
| 0.184 | 0.037 | 0.375 | Cell wall synthesis inhibitor | 0.375 0.007 CID_154699725 | CID_154699725 | |
| 0.15 | 0.004 | 0.15 | CXC chemokine 1 receptor antagonist | |||
| 0.155 | 0.01 | 0.155 | Carbonic anhydrase VA inhibitor | |||
| 0.208 | 0.064 | 0.508 | Nitric oxide antagonist | 0.508 0.015 CID_154699725 | CID_154699725 | |
| 0.162 | 0.02 | 0.162 | Sphingomyelinase inhibitor | 0.15 0.024 CID_154699725 | ||
| 0.155 | 0.013 | 0.155 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.08 0.064 CID_154699725 | ||
| 0.146 | 0.005 | 0.146 | Heat shock protein 90 beta antagonist | |||
| 0.152 | 0.011 | 0.152 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.141 | 0.002 | 0.141 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.048 0.018 CID_154699725 | ||
| 0.158 | 0.02 | 0.165 | Carbonic anhydrase XIII inhibitor | 0.165 0.019 CID_154699725 | CID_154699725 | |
| 0.185 | 0.048 | 0.373 | NOS3 expression enhancer | 0.373 0.009 CID_154699725 | CID_154699725 | |
| 0.141 | 0.005 | 0.141 | GABA B receptor agonist | |||
| 0.14 | 0.004 | 0.14 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.183 | 0.048 | 0.341 | Protein kinase stimulant | 0.341 0.013 CID_154699725 | CID_154699725 | |
| 0.152 | 0.018 | 0.152 | Electrolyte absorption antagonist | |||
| 0.251 | 0.118 | 0.251 | Thyroid hormone beta antagonist | |||
| 0.216 | 0.083 | 0.216 | MAP kinase kinase 3 inhibitor | |||
| 0.138 | 0.005 | 0.138 | NMDA receptor subunit 3A antagonist | |||
| 0.141 | 0.01 | 0.141 | Carbonic anhydrase VB inhibitor | |||
| 0.135 | 0.005 | 0.135 | Estrogen-related receptor beta agonist | |||
| 0.136 | 0.006 | 0.136 | CD45 antagonist | |||
| 0.145 | 0.016 | 0.145 | Histamine N-methyltransferase inhibitor | |||
| 0.143 | 0.014 | 0.143 | Glutathione S-transferase inhibitor | 0.084 0.055 CID_154699725 | ||
| 0.212 | 0.085 | 0.361 | Cyclic AMP phosphodiesterase inhibitor | 0.361 0.023 CID_154699725 | CID_154699725 | |
| 0.146 | 0.02 | 0.146 | Anabolic | |||
| 0.215 | 0.089 | 0.303 | Antiamyloidogenic | 0.303 0.051 CID_154699725 | CID_154699725 | |
| 0.18 | 0.054 | 0.295 | Interleukin 6 antagonist | 0.295 0.015 CID_154699725 | CID_154699725 | |
| 0.149 | 0.024 | 0.149 | Breast cancer-resistant protein inhibitor | |||
| 0.13 | 0.005 | 0.13 | Phospholipase D inhibitor | 0.074 0.044 CID_154699725 | ||
| 0.173 | 0.048 | 0.173 | Tubulin antagonist | |||
| 0.157 | 0.033 | 0.157 | Falcipain 3 inhibitor | |||
| 0.176 | 0.053 | 0.176 | Cyclooxygenase inhibitor | 0.113 0.108 CID_154699725 | ||
| 0.135 | 0.012 | 0.19 | Glycine receptor antagonist | 0.19 0.004 CID_154699725 | CID_154699725 | |
| 0.145 | 0.022 | 0.145 | Potassium channel activator | |||
| 0.139 | 0.016 | 0.139 | Cyclin B3 inhibitor | |||
| 0.131 | 0.009 | 0.131 | CDC25B inhibitor | |||
| 0.128 | 0.006 | 0.128 | Aryl hydrocarbon receptor antagonist | |||
| 0.149 | 0.029 | 0.149 | Caspase 3 inhibitor | |||
| 0.124 | 0.004 | 0.124 | Glutamate (mGluR7) antagonist | |||
| 0.122 | 0.003 | 0.122 | Dopamine D5 agonist | |||
| 0.133 | 0.015 | 0.133 | Myeloperoxidase inhibitor | |||
| 0.134 | 0.016 | 0.134 | HIV-1 integrase (3'-Processing) inhibitor | 0.064 0.044 CID_154699725 | ||
| 0.225 | 0.107 | 0.515 | Immunostimulant | 0.515 0.027 CID_154699725 | CID_154699725 | |
| 0.15 | 0.033 | 0.15 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.13 | 0.013 | 0.13 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.134 | 0.018 | 0.134 | Keratolytic | |||
| 0.17 | 0.054 | 0.17 | Thiol protease inhibitor | |||
| 0.118 | 0.003 | 0.118 | Adenylate cyclase 1 inhibitor | |||
| 0.127 | 0.012 | 0.127 | Sirtuin 1 inhibitor | |||
| 0.139 | 0.025 | 0.139 | Androgen antagonist | |||
| 0.128 | 0.014 | 0.128 | Carbamoyl phosphate synthetase inhibitor | 0.075 0.031 CID_154699725 | ||
| 0.123 | 0.01 | 0.123 | NMDA 2C receptor antagonist | |||
| 0.118 | 0.005 | 0.118 | Glutamate (mGluR4) antagonist | |||
| 0.15 | 0.038 | 0.15 | Aminopeptidase B inhibitor | |||
| 0.217 | 0.105 | 0.352 | Interleukin agonist | 0.352 0.028 CID_154699725 | CID_154699725 | |
| 0.135 | 0.023 | 0.165 | Thioredoxin inhibitor | 0.165 0.013 CID_154699725 | CID_154699725 | |
| 0.117 | 0.005 | 0.358 | Mannosidase inhibitor | 0.358 0.002 CID_154699725 | CID_154699725 | |
| 0.117 | 0.005 | 0.348 | Alpha-mannosidase inhibitor | 0.348 0.002 CID_154699725 | CID_154699725 | |
| 0.117 | 0.005 | 0.117 | MAP kinase kinase 7 inhibitor | |||
| 0.162 | 0.052 | 0.162 | Histone deacetylase SIRT1 inhibitor | |||
| 0.113 | 0.004 | 0.113 | Dopamine beta hydroxylase inhibitor | |||
| 0.167 | 0.058 | 0.41 | Insulin secretagoues | 0.41 0.006 CID_154699725 | CID_154699725 | |
| 0.15 | 0.041 | 0.174 | Beta amyloid protein antagonist | 0.174 0.027 CID_154699725 | CID_154699725 | |
| 0.112 | 0.004 | 0.112 | Dihydroorotate oxidase inhibitor | |||
| 0.124 | 0.017 | 0.124 | Aromatase inhibitor | |||
| 0.11 | 0.003 | 0.11 | Protein kinase (CK2) beta inhibitor | |||
| 0.127 | 0.021 | 0.127 | Glutamate dehydrogenase inhibitor | 0.089 0.037 CID_154699725 | ||
| 0.121 | 0.015 | 0.121 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.109 | 0.004 | 0.109 | Ryanodine receptor antagonist | |||
| 0.214 | 0.109 | 0.321 | Spasmolytic | 0.321 0.062 CID_154699725 | CID_154699725 | |
| 0.123 | 0.019 | 0.123 | Prostaglandin-E synthase inhibitor | |||
| 0.109 | 0.005 | 0.109 | MDM2 inhibitor | |||
| 0.143 | 0.039 | 0.278 | DNA repair enzyme inhibitor | 0.278 0.005 CID_154699725 | CID_154699725 | |
| 0.114 | 0.01 | 0.114 | 5 Hydroxytryptamine 2A agonist | |||
| 0.152 | 0.048 | 0.312 | Topoisomerase II inhibitor | 0.312 0.016 CID_154699725 | CID_154699725 | |
| 0.19 | 0.086 | 0.197 | Psychostimulant | 0.197 0.082 CID_154699725 | CID_154699725 | |
| 0.144 | 0.041 | 0.196 | Microtubule formation inhibitor | 0.196 0.021 CID_154699725 | CID_154699725 | |
| 0.126 | 0.024 | 0.142 | Interleukin 12 antagonist | 0.142 0.015 CID_154699725 | CID_154699725 | |
| 0.106 | 0.005 | 0.106 | Urate transporter 1 inhibitor | |||
| 0.114 | 0.012 | 0.114 | Xanthine dehydrogenase inhibitor | 0.053 0.043 CID_154699725 | ||
| 0.177 | 0.076 | 0.177 | LIM domain kinase 1 inhibitor | |||
| 0.106 | 0.005 | 0.106 | Glutamate (mGluR group III) antagonist | |||
| 0.188 | 0.087 | 0.188 | Insulin sensitizer | 0.183 0.092 CID_154699725 | ||
| 0.15 | 0.051 | 0.15 | Glutamate receptor antagonist | |||
| 0.108 | 0.009 | 0.172 | Carbonic anhydrase XIV inhibitor | 0.172 0.005 CID_154699725 | CID_154699725 | |
| 0.116 | 0.017 | 0.116 | HIV-1 integrase inhibitor | |||
| 0.112 | 0.013 | 0.112 | Purinergic P2X1 antagonist | 0.056 0.049 CID_154699725 | ||
| 0.107 | 0.008 | 0.107 | Topoisomerase II beta inhibitor | 0.072 0.016 CID_154699725 | ||
| 0.105 | 0.007 | 0.105 | Exportin-1 inhibitor | |||
| 0.119 | 0.022 | 0.119 | Carbonic anhydrase inhibitor | 0.114 0.023 CID_154699725 | ||
| 0.106 | 0.008 | 0.106 | Glutamate (mGluR6) antagonist | 0.073 0.034 CID_154699725 | ||
| 0.193 | 0.096 | 0.193 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.152 | 0.054 | 0.152 | M17 leucyl aminopeptidase inhibitor | |||
| 0.125 | 0.028 | 0.224 | Topoisomerase II alpha inhibitor | 0.224 0.012 CID_154699725 | CID_154699725 | |
| 0.155 | 0.058 | 0.155 | Neuropeptide Y1 antagonist | |||
| 0.114 | 0.017 | 0.191 | Carbonic anhydrase XII inhibitor | 0.191 0.009 CID_154699725 | CID_154699725 | |
| 0.1 | 0.004 | 0.1 | Sirtuin 2 inhibitor | |||
| 0.104 | 0.009 | 0.104 | Carbonic anhydrase VII inhibitor | 0.049 0.028 CID_154699725 | ||
| 0.124 | 0.03 | 0.124 | Protein kinase C zeta inhibitor | |||
| 0.11 | 0.016 | 0.11 | Biliverdin reductase inhibitor | 0.075 0.029 CID_154699725 | ||
| 0.114 | 0.02 | 0.133 | Na+ K+ transporting ATPase inhibitor | 0.133 0.01 CID_154699725 | CID_154699725 | |
| 0.114 | 0.021 | 0.114 | mTOR complex 2 inhibitor | |||
| 0.102 | 0.008 | 0.102 | Glucosylceramidase inhibitor | 0.071 0.021 CID_154699725 | ||
| 0.133 | 0.039 | 0.4 | AMP-activated protein kinase stimulant | 0.4 0.004 CID_154699725 | CID_154699725 | |
| 0.106 | 0.013 | 0.106 | Beta 3 adrenoreceptor antagonist | |||
| 0.106 | 0.014 | 0.106 | NMDA receptor glycine site agonist | |||
| 0.096 | 0.005 | 0.096 | Purinergic P2X4 antagonist | |||
| 0.182 | 0.092 | 0.182 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.095 | 0.005 | 0.095 | Potassium channel (Inward rectifier) activator | |||
| 0.095 | 0.005 | 0.097 | Adenine nucleotide translocase inhibitor | 0.097 0.005 CID_154699725 | CID_154699725 | |
| 0.095 | 0.006 | 0.095 | Squalene epoxidase inhibitor | 0.049 0.037 CID_154699725 | ||
| 0.145 | 0.057 | 0.145 | Cyclooxygenase 2 inhibitor | |||
| 0.092 | 0.005 | 0.092 | Potassium channel (ATP-sensitive) activator | |||
| 0.109 | 0.022 | 0.109 | Dopamine D1 antagonist | |||
| 0.1 | 0.015 | 0.1 | Alpha 2 adrenoreceptor agonist | |||
| 0.113 | 0.029 | 0.113 | Adrenaline agonist | |||
| 0.154 | 0.07 | 0.154 | Phospholipase A2 inhibitor | 0.135 0.092 CID_154699725 | ||
| 0.112 | 0.029 | 0.112 | Bile acid receptor antagonist | |||
| 0.15 | 0.067 | 0.15 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.095 | 0.012 | 0.095 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.107 | 0.024 | 0.107 | Aminopeptidase I inhibitor | |||
| 0.102 | 0.02 | 0.132 | Carbonic anhydrase IX inhibitor | 0.132 0.014 CID_154699725 | CID_154699725 | |
| 0.101 | 0.019 | 0.101 | NMDA receptor agonist | |||
| 0.096 | 0.015 | 0.113 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.113 0.012 CID_154699725 | CID_154699725 | |
| 0.091 | 0.01 | 0.091 | Aconitate hydratase inhibitor | |||
| 0.097 | 0.017 | 0.097 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.041 CID_154699725 | ||
| 0.135 | 0.054 | 0.165 | CC chemokine 6 receptor antagonist | 0.165 0.01 CID_154699725 | CID_154699725 | |
| 0.102 | 0.022 | 0.102 | HIV-1 integrase (Strand Transfer) inhibitor | 0.054 0.046 CID_154699725 | ||
| 0.082 | 0.002 | 0.082 | Estrogen-related receptor gamma antagonist | |||
| 0.086 | 0.007 | 0.131 | Glucose-6-phosphate isomerase inhibitor | 0.131 0.003 CID_154699725 | CID_154699725 | |
| 0.084 | 0.005 | 0.084 | GABA B receptor antagonist | |||
| 0.083 | 0.004 | 0.083 | Heme oxygenase inhibitor | |||
| 0.104 | 0.025 | 0.104 | Thioredoxin reductase inhibitor | |||
| 0.105 | 0.027 | 0.105 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.088 | 0.01 | 0.088 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.089 | 0.012 | 0.089 | Cyclin D1 inhibitor | |||
| 0.097 | 0.019 | 0.097 | Vanilloid 4 agonist | |||
| 0.135 | 0.058 | 0.135 | Vanilloid 1 agonist | 0.124 0.079 CID_154699725 | ||
| 0.096 | 0.02 | 0.096 | Carbonic anhydrase II inhibitor | 0.08 0.025 CID_154699725 | ||
| 0.128 | 0.051 | 0.288 | Topoisomerase I inhibitor | 0.288 0.012 CID_154699725 | CID_154699725 | |
| 0.083 | 0.006 | 0.083 | Nicotinic acid receptor agonist | |||
| 0.089 | 0.012 | 0.089 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.08 | 0.004 | 0.08 | ATP citrate lysase inhibitor | |||
| 0.103 | 0.027 | 0.103 | Histone deacetylase SIRT2 inhibitor | |||
| 0.194 | 0.118 | 0.733 | Hypoglycemic | 0.733 0.005 CID_154699725 | CID_154699725 | |
| 0.099 | 0.023 | 0.099 | CC chemokine 5 receptor agonist | |||
| 0.079 | 0.003 | 0.079 | CF transmembrane conductance regulator antagonist | |||
| 0.086 | 0.013 | 0.086 | Transcription factor RelA inhibitor | |||
| 0.08 | 0.007 | 0.08 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.131 | 0.059 | 0.131 | Anesthetic local | |||
| 0.122 | 0.05 | 0.122 | Nav1.4 sodium channel blocker | |||
| 0.131 | 0.058 | 0.256 | Alkylator | 0.256 0.016 CID_154699725 | CID_154699725 | |
| 0.096 | 0.023 | 0.096 | Glycine receptor agonist | 0.085 0.033 CID_154699725 | ||
| 0.139 | 0.068 | 0.139 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.092 | 0.021 | 0.092 | Carbonic anhydrase I inhibitor | 0.083 0.024 CID_154699725 | ||
| 0.1 | 0.029 | 0.135 | Interferon agonist | 0.135 0.013 CID_154699725 | CID_154699725 | |
| 0.078 | 0.007 | 0.078 | Fumarate hydratase inhibitor | 0.058 0.011 CID_154699725 | ||
| 0.094 | 0.023 | 0.094 | Acetylcholine M5 receptor agonist | |||
| 0.136 | 0.065 | 0.136 | Interleukin 4 antagonist | 0.134 0.067 CID_154699725 | ||
| 0.122 | 0.051 | 0.122 | Protein kinase C gamma inhibitor | |||
| 0.112 | 0.041 | 0.112 | Antineoplastic alkaloid | |||
| 0.08 | 0.01 | 0.08 | Kainate receptor antagonist | |||
| 0.077 | 0.008 | 0.379 | Heparanase inhibitor | 0.379 0.001 CID_154699725 | CID_154699725 | |
| 0.09 | 0.022 | 0.09 | Argininosuccinate synthase inhibitor | 0.063 0.035 CID_154699725 | ||
| 0.076 | 0.007 | 0.076 | AMPA 4 receptor antagonist | |||
| 0.105 | 0.036 | 0.112 | Glutamate release inhibitor | 0.112 0.028 CID_154699725 | CID_154699725 | |
| 0.145 | 0.078 | 0.145 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.088 | 0.02 | 0.088 | Androgen agonist | |||
| 0.088 | 0.021 | 0.088 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.148 | 0.081 | 0.148 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.144 | 0.078 | 0.144 | MAP kinase 3 inhibitor | |||
| 0.14 | 0.075 | 0.14 | Pregnane X receptor agonist | |||
| 0.082 | 0.017 | 0.082 | Beta 1 adrenoreceptor antagonist | |||
| 0.127 | 0.063 | 0.169 | DNA polymerase I inhibitor | 0.169 0.04 CID_154699725 | CID_154699725 | |
| 0.219 | 0.155 | 0.643 | Antithrombotic | 0.643 0.012 CID_154699725 | CID_154699725 | |
| 0.099 | 0.036 | 0.099 | Opioid kappa receptor antagonist | |||
| 0.106 | 0.043 | 0.106 | Opioid antagonist | |||
| 0.086 | 0.023 | 0.086 | Beta adrenoreceptor antagonist | |||
| 0.082 | 0.019 | 0.082 | Alpha tubulin antagonist | |||
| 0.088 | 0.026 | 0.088 | Beta tubulin antagonist | |||
| 0.069 | 0.006 | 0.069 | Glutamate (mGluR3) antagonist | |||
| 0.079 | 0.017 | 0.079 | AMPA receptor antagonist | |||
| 0.078 | 0.016 | 0.078 | Cyclin B2 inhibitor | |||
| 0.075 | 0.014 | 0.075 | Beta 2 adrenoreceptor antagonist | |||
| 0.1 | 0.039 | 0.1 | Acetylcholine nicotinic antagonist | |||
| 0.09 | 0.029 | 0.09 | Neuronal nicotinic receptor antagonist | |||
| 0.116 | 0.056 | 0.124 | Acetylcholine release stimulant | 0.124 0.043 CID_154699725 | CID_154699725 | |
| 0.082 | 0.022 | 0.107 | Interferon inducer | 0.107 0.01 CID_154699725 | CID_154699725 | |
| 0.092 | 0.032 | 0.092 | CDC25A inhibitor | |||
| 0.126 | 0.067 | 0.126 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.107 | 0.048 | 0.107 | Glutamate (mGluR7) agonist | |||
| 0.076 | 0.018 | 0.076 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.068 | 0.013 | 0.068 | Immunoglobulin Fc receptor antagonist | |||
| 0.073 | 0.017 | 0.073 | Plasminogen activator inhibitor antagonist | |||
| 0.153 | 0.097 | 0.153 | Tumour necrosis factor antagonist | |||
| 0.062 | 0.006 | 0.062 | Kainate receptor agonist | |||
| 0.06 | 0.005 | 0.06 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.131 | 0.076 | 0.131 | Toll-Like receptor 9 antagonist | |||
| 0.066 | 0.013 | 0.066 | CDK5/p25 inhibitor | |||
| 0.074 | 0.021 | 0.074 | Botulinum neurotoxin type A inhibitor | |||
| 0.062 | 0.009 | 0.062 | RNA-directed RNA polymerase inhibitor | |||
| 0.077 | 0.025 | 0.077 | Cyclin B1 inhibitor | |||
| 0.066 | 0.014 | 0.066 | Thymidylate synthase inhibitor | |||
| 0.056 | 0.005 | 0.056 | CXC chemokine 2 receptor antagonist | |||
| 0.058 | 0.008 | 0.058 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.058 | 0.008 | 0.058 | HCV NS5B polymerase inhibitor | |||
| 0.053 | 0.004 | 0.053 | Thyroid hormone alpha antagonist | |||
| 0.053 | 0.004 | 0.053 | Thyroid hormone agonist | |||
| 0.114 | 0.066 | 0.114 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.053 | 0.005 | 0.053 | Ceramide glucosyltransferase inhibitor | 0.053 0.005 CID_154699725 | ||
| 0.07 | 0.022 | 0.07 | Cyclin B inhibitor | |||
| 0.069 | 0.021 | 0.069 | Beta 2 adrenoreceptor agonist | |||
| 0.061 | 0.013 | 0.061 | Geranyltranstransferase inhibitor | |||
| 0.087 | 0.04 | 0.087 | Metalloproteinase-9 inhibitor | |||
| 0.211 | 0.164 | 0.211 | Vasodilator, peripheral | 0.195 0.181 CID_154699725 | ||
| 0.056 | 0.01 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.049 | 0.003 | 0.049 | Estrogen-related receptor gamma agonist | |||
| 0.06 | 0.014 | 0.06 | Thymidine kinase inhibitor | |||
| 0.107 | 0.061 | 0.248 | Mediator release inhibitor | 0.248 0.01 CID_154699725 | CID_154699725 | |
| 0.068 | 0.023 | 0.068 | Sphingosine kinase 2 inhibitor | |||
| 0.07 | 0.025 | 0.07 | Fatty acid synthase inhibitor | |||
| 0.087 | 0.043 | 0.087 | Alpha 2a adrenoreceptor antagonist | |||
| 0.081 | 0.037 | 0.081 | Alpha adrenoreceptor agonist | |||
| 0.052 | 0.007 | 0.052 | Vanilloid 3 antagonist | |||
| 0.057 | 0.013 | 0.057 | Kainate receptor 2 antagonist | |||
| 0.087 | 0.044 | 0.087 | Catalase inhibitor | |||
| 0.054 | 0.011 | 0.054 | Potassium channel Kv1.1 blocker | |||
| 0.082 | 0.039 | 0.082 | Opioid mu receptor antagonist | |||
| 0.055 | 0.013 | 0.055 | Histamine H1 receptor agonist | |||
| 0.111 | 0.069 | 0.111 | Interleukin 1b antagonist | |||
| 0.05 | 0.009 | 0.05 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.133 | 0.092 | 0.133 | Acetylcholine M1 receptor antagonist | |||
| 0.049 | 0.007 | 0.049 | NMDA 2D receptor antagonist | |||
| 0.047 | 0.006 | 0.047 | LFA antagonist | |||
| 0.064 | 0.023 | 0.064 | Pregnane X receptor antagonist | |||
| 0.059 | 0.018 | 0.059 | Erythropoietin receptor agonist | |||
| 0.065 | 0.024 | 0.065 | 5 Hydroxytryptamine 7 agonist | |||
| 0.052 | 0.013 | 0.052 | Estrogen-related receptor alpha antagonist | |||
| 0.059 | 0.02 | 0.059 | Carbonic anhydrase IV inhibitor | |||
| 0.051 | 0.011 | 0.051 | Glutamate (mGluR8) agonist | |||
| 0.097 | 0.058 | 0.139 | Phosphodiesterase 6D inhibitor | 0.139 0.013 CID_154699725 | CID_154699725 | |
| 0.046 | 0.007 | 0.046 | NMDA receptor glycine site antagonist | |||
| 0.082 | 0.043 | 0.082 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.108 | 0.069 | 0.108 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.043 | 0.004 | 0.043 | Nicotinic acid receptor 2 antagonist | |||
| 0.048 | 0.01 | 0.048 | AMPA 3 receptor antagonist | |||
| 0.044 | 0.005 | 0.044 | Thymidine phosphorylase inhibitor | 0.025 0.021 CID_154699725 | ||
| 0.057 | 0.019 | 0.057 | Oxytocin agonist | |||
| 0.049 | 0.011 | 0.049 | AMPA 1 receptor antagonist | |||
| 0.076 | 0.038 | 0.076 | Opioid delta receptor antagonist | |||
| 0.111 | 0.074 | 0.111 | Proteasome inhibitor | |||
| 0.058 | 0.022 | 0.058 | Adenosine deaminase inhibitor | 0.055 0.025 CID_154699725 | ||
| 0.051 | 0.015 | 0.051 | Alpha 1d adrenoreceptor agonist | |||
| 0.062 | 0.026 | 0.062 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.046 | 0.011 | 0.046 | Sigma 2 receptor antagonist | |||
| 0.039 | 0.003 | 0.039 | Nicotinic acid receptor 1 antagonist | |||
| 0.076 | 0.041 | 0.076 | Secretase beta inhibitor | |||
| 0.043 | 0.008 | 0.043 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.045 | 0.011 | 0.045 | Catechol O-methyltransferase inhibitor | |||
| 0.049 | 0.014 | 0.049 | 5 Hydroxytryptamine 2B agonist | |||
| 0.038 | 0.005 | 0.038 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.152 | 0.119 | 0.152 | Death-associated protein kinase 3 inhibitor | |||
| 0.077 | 0.044 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.04 | 0.007 | 0.04 | Kainate receptor 1 antagonist | |||
| 0.054 | 0.022 | 0.054 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.04 | 0.008 | 0.04 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.095 | 0.064 | 0.095 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.035 | 0.004 | 0.035 | Isoleucine-tRNA ligase inhibitor | 0.034 0.004 CID_154699725 | ||
| 0.051 | 0.02 | 0.062 | Guanylate cyclase inhibitor | 0.062 0.01 CID_154699725 | CID_154699725 | |
| 0.036 | 0.004 | 0.036 | Complement factor 1s inhibitor | |||
| 0.035 | 0.004 | 0.035 | NMDA receptor phencyclidine site antagonist | |||
| 0.06 | 0.029 | 0.06 | Leukotriene C antagonist | |||
| 0.088 | 0.058 | 0.088 | Ornithine decarboxylase inhibitor | |||
| 0.084 | 0.053 | 0.084 | Caspase 7 inhibitor | |||
| 0.059 | 0.029 | 0.059 | Lysine-specific demethylase 1A inhibitor | |||
| 0.074 | 0.044 | 0.074 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.081 | 0.051 | 0.081 | Metalloproteinase-2 inhibitor | |||
| 0.066 | 0.037 | 0.066 | TRPA1 antagonist | |||
| 0.076 | 0.047 | 0.076 | Cathepsin G inhibitor | |||
| 0.039 | 0.011 | 0.039 | Glutamate (mGluR3) agonist | |||
| 0.06 | 0.032 | 0.06 | Thromboxane antagonist | |||
| 0.085 | 0.057 | 0.085 | Bcr-Abl kinase inhibitor | |||
| 0.032 | 0.005 | 0.032 | ICAM 1 antagonist | |||
| 0.067 | 0.039 | 0.067 | 5 Hydroxytryptamine 3 agonist | |||
| 0.082 | 0.055 | 0.082 | Acetylcholine nicotinic agonist | |||
| 0.034 | 0.007 | 0.034 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.022 CID_154699725 | ||
| 0.088 | 0.061 | 0.088 | Pim-3 kinase inhibitor | |||
| 0.03 | 0.003 | 0.042 | Telomerase stimulant | 0.042 0.002 CID_154699725 | CID_154699725 | |
| 0.033 | 0.007 | 0.033 | Prostaglandin F2 alpha agonist | |||
| 0.141 | 0.116 | 0.485 | Platelet adhesion inhibitor | 0.485 0.005 CID_154699725 | CID_154699725 | |
| 0.092 | 0.067 | 0.092 | DNA directed RNA polymerase inhibitor | |||
| 0.03 | 0.005 | 0.03 | Alpha 2a adrenoreceptor agonist | |||
| 0.058 | 0.033 | 0.058 | NMDA 2B receptor antagonist | |||
| 0.058 | 0.033 | 0.058 | Ornithine carbamoyltransferase inhibitor | |||
| 0.062 | 0.038 | 0.062 | Carbonic anhydrase stimulant | |||
| 0.047 | 0.022 | 0.047 | Liver X receptor alpha agonist | |||
| 0.056 | 0.032 | 0.056 | 5 Hydroxytryptamine 2 agonist | |||
| 0.029 | 0.005 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.032 | 0.008 | 0.051 | Vanilloid 2 agonist | 0.051 0.003 CID_154699725 | CID_154699725 | |
| 0.063 | 0.04 | 0.063 | Histone deacetylase SIRT3 inhibitor | |||
| 0.051 | 0.028 | 0.051 | Opioid mu receptor agonist | |||
| 0.044 | 0.022 | 0.044 | Dihydropteroate synthase inhibitor | |||
| 0.119 | 0.097 | 0.119 | Nav1.6 sodium channel blocker | |||
| 0.033 | 0.011 | 0.121 | Sodium/glucose cotransporter 2 inhibitor | 0.121 0.002 CID_154699725 | CID_154699725 | |
| 0.056 | 0.034 | 0.056 | Thromboxane synthase inhibitor | |||
| 0.045 | 0.024 | 0.045 | Alpha 1L adrenoreceptor agonist | |||
| 0.041 | 0.02 | 0.041 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.128 | 0.107 | 0.128 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.026 | 0.005 | 0.026 | Alpha 2b adrenoreceptor agonist | |||
| 0.04 | 0.02 | 0.04 | p53 inhibitor | |||
| 0.023 | 0.003 | 0.023 | Progesterone receptor A antagonist | |||
| 0.03 | 0.01 | 0.03 | Adenosine kinase inhibitor | |||
| 0.033 | 0.013 | 0.033 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.035 | 0.015 | 0.035 | Epoxide hydrolase 1 inhibitor | |||
| 0.036 | 0.016 | 0.036 | Peptide deformylase inhibitor | |||
| 0.052 | 0.033 | 0.052 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.033 | 0.015 | 0.05 | Uridine phosphorylase inhibitor | 0.05 0.008 CID_154699725 | CID_154699725 | |
| 0.052 | 0.034 | 0.052 | Thromboxane A2 antagonist | |||
| 0.046 | 0.028 | 0.046 | Beta adrenoreceptor agonist | |||
| 0.072 | 0.055 | 0.072 | Adenosine A3 receptor antagonist | |||
| 0.037 | 0.019 | 0.037 | Tubulin agonist | |||
| 0.068 | 0.051 | 0.068 | Protein kinase C beta inhibitor | |||
| 0.031 | 0.015 | 0.031 | Purinergic P2Y15 antagonist | |||
| 0.03 | 0.014 | 0.03 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.027 | 0.011 | 0.027 | Prostaglandin EP1 antagonist | |||
| 0.039 | 0.023 | 0.039 | Progesterone antagonist | |||
| 0.065 | 0.05 | 0.065 | CDC7 inhibitor | |||
| 0.019 | 0.004 | 0.019 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.019 | 0.004 | 0.019 | Integrin beta6 antagonist | |||
| 0.022 | 0.007 | 0.022 | CXC chemokine 5 receptor antagonist | |||
| 0.022 | 0.008 | 0.036 | Antibiotic Anthracycline-like | 0.036 0.003 CID_154699725 | CID_154699725 | |
| 0.167 | 0.153 | 0.167 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.033 | 0.019 | 0.033 | Prostaglandin agonist | |||
| 0.148 | 0.134 | 0.148 | Focal adhesion kinase 2 inhibitor | |||
| 0.056 | 0.042 | 0.056 | Glutamate (mGluR1) antagonist | |||
| 0.016 | 0.002 | 0.016 | DNA topoisomerase III inhibitor | |||
| 0.041 | 0.028 | 0.041 | Plasmepsin II inhibitor | |||
| 0.027 | 0.015 | 0.108 | Sodium/glucose cotransporter inhibitor | 0.108 0.002 CID_154699725 | CID_154699725 | |
| 0.046 | 0.034 | 0.046 | Potassium channel Kv1.3 blocker | |||
| 0.04 | 0.027 | 0.04 | Membrane dipeptidase inhibitor | |||
| 0.032 | 0.02 | 0.032 | Cyclophilin A inhibitor | |||
| 0.027 | 0.015 | 0.027 | Acid ceramidase inhibitor | |||
| 0.019 | 0.008 | 0.019 | Thyroid hormone alpha agonist | |||
| 0.02 | 0.009 | 0.056 | Ileal bile acid transport inhibitor | 0.056 0.003 CID_154699725 | CID_154699725 | |
| 0.038 | 0.027 | 0.038 | Retinoid X receptor antagonist | |||
| 0.027 | 0.016 | 0.027 | Prostaglandin H2 antagonist | |||
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | |||
| 0.066 | 0.055 | 0.066 | CXC chemokine receptor antagonist | |||
| 0.047 | 0.036 | 0.06 | Cytokine production stimulant | 0.06 0.013 CID_154699725 | CID_154699725 | |
| 0.024 | 0.013 | 0.033 | Dopamine D1 agonist | 0.033 0.008 CID_154699725 | CID_154699725 | |
| 0.052 | 0.041 | 0.052 | GABA receptor antagonist | |||
| 0.032 | 0.021 | 0.032 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.03 | 0.019 | 0.03 | MAP3K8 inhibitor | |||
| 0.039 | 0.028 | 0.039 | Leukotriene C4 antagonist | |||
| 0.056 | 0.046 | 0.056 | Sphingosine kinase inhibitor | |||
| 0.035 | 0.025 | 0.035 | Phosphoglycerate kinase inhibitor | |||
| 0.014 | 0.004 | 0.014 | Thyroid hormone beta agonist | |||
| 0.015 | 0.006 | 0.015 | Carbonic anhydrase XI inhibitor | |||
| 0.054 | 0.045 | 0.054 | Dopamine uptake inhibitor | |||
| 0.039 | 0.03 | 0.039 | Nicotinic acid receptor 1 agonist | |||
| 0.038 | 0.029 | 0.038 | MAP3K5 inhibitor | |||
| 0.06 | 0.051 | 0.06 | Leukotriene antagonist | |||
| 0.041 | 0.032 | 0.041 | Histamine H2 receptor agonist | |||
| 0.036 | 0.027 | 0.036 | Kinesin antagonist | |||
| 0.036 | 0.027 | 0.036 | Kinesin-like protein 1 inhibitor | |||
| 0.054 | 0.046 | 0.054 | Cathepsin L inhibitor | |||
| 0.024 | 0.016 | 0.024 | Prostaglandin E2 agonist | |||
| 0.078 | 0.07 | 0.078 | Insulin growth factor antagonist | |||
| 0.017 | 0.01 | 0.017 | Nicotinic alpha4 receptor agonist | |||
| 0.026 | 0.019 | 0.026 | Sigma 1 receptor antagonist | |||
| 0.021 | 0.014 | 0.021 | Retinoid X beta receptor antagonist | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.028 | 0.022 | 0.028 | 5 Hydroxytryptamine 6 agonist | |||
| 0.062 | 0.057 | 0.062 | HIV-1 reverse transcriptase inhibitor | |||
| 0.056 | 0.05 | 0.056 | Cannabinoid CB1 receptor antagonist | |||
| 0.017 | 0.012 | 0.017 | CC chemokine 9 receptor antagonist | |||
| 0.026 | 0.021 | 0.026 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.045 | 0.04 | 0.045 | Benzodiazepine antagonist | |||
| 0.028 | 0.023 | 0.028 | AMPA 2 receptor antagonist | |||
| 0.064 | 0.059 | 0.064 | Amidase inhibitor | |||
| 0.021 | 0.017 | 0.021 | Glutamate (mGluR1a) agonist | |||
| 0.068 | 0.064 | 0.068 | Analgesic, opioid | |||
| 0.032 | 0.028 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.018 | 0.014 | 0.018 | Alpha 2c adrenoreceptor agonist | |||
| 0.036 | 0.032 | 0.036 | GABA uptake inhibitor | |||
| 0.025 | 0.021 | 0.025 | Lysine carboxypeptidase inhibitor | |||
| 0.019 | 0.015 | 0.019 | Progesterone receptor B antagonist | |||
| 0.164 | 0.16 | 0.436 | Peptidyltransferase inhibitor | 0.436 0.005 CID_154699725 | CID_154699725 | |
| 0.016 | 0.013 | 0.016 | G-protein-coupled receptor 120 agonist | |||
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.041 | 0.037 | 0.041 | Dihydrofolate reductase inhibitor | |||
| 0.02 | 0.017 | 0.02 | Factor XIII inhibitor | |||
| 0.015 | 0.012 | 0.015 | Antibiotic Tetracycline-like | |||
| 0.064 | 0.061 | 0.064 | Benzodiazepine agonist | |||
| 0.107 | 0.104 | 0.107 | Antibacterial (Helicobacter pylori) | |||
| 0.052 | 0.049 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.033 | 0.031 | 0.033 | Adenosine uptake inhibitor | |||
| 0.032 | 0.03 | 0.063 | Arginase inhibitor | 0.063 0.009 CID_154699725 | CID_154699725 | |
| 0.007 | 0.005 | 0.007 | Integrin alpha5beta6 antagonist | |||
| 0.013 | 0.011 | 0.013 | Integrin alphaVbeta6 antagonist | |||
| 0.01 | 0.008 | 0.015 | Purinergic P2Y2 agonist | 0.015 0.003 CID_154699725 | CID_154699725 | |
| 0.013 | 0.011 | 0.013 | Cyclin D2 inhibitor | |||
| 0.017 | 0.015 | 0.017 | Complement factor D inhibitor | |||
| 0.038 | 0.037 | 0.038 | Glutamate (mGluR group III) agonist | |||
| 0.04 | 0.038 | 0.04 | AICAR transformylase inhibitor | |||
| 0.075 | 0.073 | 0.075 | Alpha 2 adrenoreceptor antagonist | |||
| 0.017 | 0.016 | 0.017 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.02 | 0.019 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.018 | 0.017 | 0.018 | Kainate receptor 5 antagonist | |||
| 0.012 | 0.011 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.011 | 0.01 | 0.011 | Integrin beta2 antagonist | |||
| 0.131 | 0.132 | 0.547 | Hepatoprotectant | 0.547 0.005 CID_154699725 | CID_154699725 | |
| 0.048 | 0.05 | 0.065 | Leukotriene B4 antagonist | 0.065 0.023 CID_154699725 | CID_154699725 | |
| 0.026 | 0.029 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.01 CID_154699725 | CID_154699725 | |
| 0.107 | 0.122 | 0.246 | Diuretic | 0.246 0.031 CID_154699725 | CID_154699725 | |
| 0.054 | 0.071 | 0.127 | Neuraminidase (influenza) inhibitor | 0.127 0.01 CID_154699725 | CID_154699725 | |
| 0.05 | 0.068 | 0.074 | Lipocortins synthesis agonist | 0.074 0.018 CID_154699725 | CID_154699725 | |
| 0.112 | 0.132 | 0.401 | Hemostatic | 0.401 0.008 CID_154699725 | CID_154699725 | |
| 0.016 | 0.04 | 0.078 | Protein 30S ribosomal subunit inhibitor | 0.078 0.004 CID_154699725 | CID_154699725 | |
| 0.187 | 0.213 | 0.462 | Interleukin 2 agonist | 0.462 0.013 CID_154699725 | CID_154699725 | |
| 0.064 | 0.097 | 0.135 | Falcipain 2 inhibitor | 0.135 0.035 CID_154699725 | CID_154699725 | |
| 0.065 | 0.101 | 0.137 | Falcipain inhibitor | 0.137 0.037 CID_154699725 | CID_154699725 | |
| 0.013 | 0.049 | 0.02 | Leukotriene B4 receptor 2 antagonist | 0.02 0.019 CID_154699725 | CID_154699725 | |
| 0.099 | 0.136 | 0.392 | Thrombolytic | 0.392 0.012 CID_154699725 | CID_154699725 | |
| 0.036 | 0.074 | 0.069 | Prostaglandin EP2 antagonist | 0.069 0.034 CID_154699725 | CID_154699725 | |
| 0.026 | 0.066 | 0.097 | Phosphorylase inhibitor | 0.097 0.013 CID_154699725 | CID_154699725 | |
| 0.036 | 0.083 | 0.476 | Selectin antagonist | 0.476 0.003 CID_154699725 | CID_154699725 | |
| 0.003 | 0.054 | 0.013 | Purinergic receptor agonist | 0.013 0.012 CID_154699725 | CID_154699725 | |
| 0.003 | 0.054 | 0.013 | Purinergic P2 agonist | 0.013 0.012 CID_154699725 | CID_154699725 | |
| 0.038 | 0.09 | 0.056 | Factor III inhibitor | 0.056 0.022 CID_154699725 | CID_154699725 | |
| 0.01 | 0.062 | 0.021 | Corticosteroid-like | 0.021 0.014 CID_154699725 | CID_154699725 | |
| 0.077 | 0.137 | 0.095 | Folate antagonist | 0.095 0.076 CID_154699725 | CID_154699725 | |
| 0.032 | 0.095 | 0.105 | Neuraminidase inhibitor | 0.105 0.014 CID_154699725 | CID_154699725 | |
| 0.018 | 0.095 | 0.041 | Toll-Like receptor 4 agonist | 0.041 0.005 CID_154699725 | CID_154699725 | |
| 0.199 | 0.277 | 0.849 | Cyclophilin D inhibitor | 0.849 0.005 CID_154699725 | CID_154699725 | |
| 0.033 | 0.117 | 0.252 | Antineoplastic antibiotic | 0.252 0.014 CID_154699725 | CID_154699725 | |
| 0.032 | 0.116 | 0.108 | Glucose-6-phosphate translocase inhibitor | 0.108 0.005 CID_154699725 | CID_154699725 | |
| 0.007 | 0.093 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.012 CID_154699725 | CID_154699725 | |
| 0.041 | 0.129 | 0.108 | Histone deacetylase stimulant | 0.108 0.023 CID_154699725 | CID_154699725 | |
| 0.041 | 0.129 | 0.108 | Histone deacetylase SIRT1 stimulant | 0.108 0.023 CID_154699725 | CID_154699725 | |
| 0.075 | 0.171 | 0.412 | Cell adhesion inhibitor | 0.412 0.005 CID_154699725 | CID_154699725 | |
| 0.05 | 0.156 | 0.25 | Cell adhesion molecule inhibitor | 0.25 0.006 CID_154699725 | CID_154699725 | |
| 0.064 | 0.174 | 0.178 | Toll-Like receptor 4 antagonist | 0.178 0.01 CID_154699725 | CID_154699725 | |
| 0.028 | 0.141 | 0.119 | Factor IXa inhibitor | 0.119 0.006 CID_154699725 | CID_154699725 | |
| 0.021 | 0.147 | 0.143 | Protein 50S ribosomal subunit inhibitor | 0.143 0.007 CID_154699725 | CID_154699725 | |
| 0.045 | 0.197 | 0.154 | DNA intercalator | 0.154 0.041 CID_154699725 | CID_154699725 | |
| 0.02 | 0.174 | 0.053 | Microtubule stabilization | 0.053 0.024 CID_154699725 | CID_154699725 | |
| 0.06 | 0.215 | 0.105 | T cell inhibitor | 0.105 0.02 CID_154699725 | CID_154699725 | |
| 0.018 | 0.178 | 0.061 | Neuraminidase (Influenza A) inhibitor | 0.061 0.012 CID_154699725 | CID_154699725 | |
| 0.018 | 0.191 | 0.094 | Antibiotic Aminoglycoside-like | 0.094 0.003 CID_154699725 | CID_154699725 | |
| 0.005 | 0.184 | 0.049 | Squalene synthetase inhibitor | 0.049 0.015 CID_154699725 | CID_154699725 | |
| 0.078 | 0.261 | 0.148 | P-glycoprotein inhibitor | 0.148 0.121 CID_154699725 | CID_154699725 | |
| 0.048 | 0.252 | 0.173 | Transcription factor NF kappa B stimulant | 0.173 0.012 CID_154699725 | CID_154699725 | |
| 0.042 | 0.265 | 0.108 | Multidrug resistance-associated protein 1 inhibitor | 0.108 0.065 CID_154699725 | CID_154699725 | |
| 0.006 | 0.24 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.01 CID_154699725 | CID_154699725 | |
| 0.075 | 0.315 | 0.349 | Vasodilator | 0.349 0.034 CID_154699725 | CID_154699725 | |
| 0.098 | 0.338 | 0.321 | Angiogenesis inhibitor | 0.321 0.083 CID_154699725 | CID_154699725 | |
| 0.001 | 0.265 | 0.016 | Antibiotic Macrolide-like | 0.016 0.009 CID_154699725 | CID_154699725 | |
| 0.051 | 0.344 | 0.332 | Hypolipemic | 0.332 0.04 CID_154699725 | CID_154699725 | |
| 0.015 | 0.352 | 0.074 | Nitric oxide donor | 0.074 0.028 CID_154699725 | CID_154699725 | |
| 0.023 | 0.375 | 0.129 | ATPase (Vacuolar H+) inhibitor | 0.129 0.014 CID_154699725 | CID_154699725 | |
| 0.061 | 0.431 | 0.524 | Immunosuppressant | 0.524 0.027 CID_154699725 | CID_154699725 | |
| 0.012 | 0.396 | 0.066 | DNA gyrase inhibitor | 0.066 0.041 CID_154699725 | CID_154699725 | |
| 0.039 | 0.477 | 0.453 | Tumour necrosis factor alpha release inhibitor | 0.453 0.019 CID_154699725 | CID_154699725 | |
| 0.031 | 0.482 | 0.351 | Platelet antagonist | 0.351 0.038 CID_154699725 | CID_154699725 | |
| 0.092 | 0.552 | 0.793 | Antiinflammatory | 0.793 0.016 CID_154699725 | CID_154699725 | |
| 0.045 | 0.554 | 0.256 | Antiobesity | 0.256 0.151 CID_154699725 | CID_154699725 | |
| 0.01 | 0.689 | 0.273 | Anticoagulant | 0.273 0.034 CID_154699725 | CID_154699725 | |
| 0.02 | 0.8 | 0.46 | Immunomodulator | 0.46 0.029 CID_154699725 | CID_154699725 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |